The Remedy Room — The Fight Beyond the Floor
The State Battlefield
States are not waiting for Congress. They are passing laws, winning bipartisan votes, and watching CVS file lawsuits the same afternoon the governor signs. This is the documented record of what states have accomplished, what it costs them, and why it proves — rather than replaces — the necessity of federal action.
The Core Argument of This Page
Every state-level PBM reform victory proves the diagnosis is correct — and simultaneously proves the diagnosis cannot be cured at the state level. ERISA creates a federal ceiling that no state law can pierce. The 39 Attorneys General who wrote to Congress in April 2025 understood this. CVS's lawyers understand this. The question is whether Congress will act before the litigation works backwards through every state that tried.
S.3822 is the legislation the states are pointing toward when they ask Congress for federal action. It operates where ERISA lives. That is the only place this ends.
On This Page
- I. The 39 AGs Letter — Primary Source Document
- II. The ERISA Ceiling — Why State Victories Are Partial by Design
- III. Tennessee — Passed, Signed, Sued Same Day
- IV. Arkansas — The First State, The First Lawsuit
- V. Virginia — The ERISA Demonstration
- VI. The Pattern — What CVS's Lawsuits Prove
- VII. The Bridge — Why This Points to S.3822
- VIII. The Parity Track — Mental Health, Ryan Matlock & Rhode Island
Section I · Primary Source Document · April 14, 2025
39 Attorneys General. 2 Parties. 1 Ask. Congress Has Not Acted.
On April 14, 2025, the National Association of Attorneys General transmitted a letter signed by 39 state and territory attorneys general to the four congressional leaders — Speaker Johnson, Majority Leader Thune, Minority Leader Schumer, and Minority Leader Jeffries. The letter has one ask: pass an act prohibiting PBMs, their parent companies, or affiliates from owning or operating pharmacies.
The Four Co-Leads — The Bipartisan Signal
R · Arkansas
Tim Griffin
D · Massachusetts
Andrea Joy Campbell
R · Missouri
Andrew Bailey
D · Vermont
Charity Clark
Deep red and deep blue. Co-signing the same letter to all four congressional leaders. Both parties. One ask.
Not a Blue-State Problem — Republican AGs Who Signed
Note: Virginia's Republican AG Jason Miyares signed the federal letter in April 2025 — the same state where the Democratic governor signed prior authorization reform into law in April 2026. Opposite parties. Same diagnosis.
Key Language — From the Letter Itself
"We, the undersigned State Attorneys General, write to the 119th United States Congress regarding the threat posed to the health and healthcare of the American people stemming from the increasingly consolidated healthcare market under the control of Pharmacy Benefit Managers. The undersigned State AGOs urge this Congress to address one of the threats posed by PBMs by passing an act prohibiting PBMs, their parent companies, or affiliates from owning or operating pharmacies."
"The three largest PBMs process 80% of the nation's prescriptions and bring in 70% of the specialty drug revenue. Each of the top six PBMs operate their own affiliated pharmacies, while five of the top six are also a part of parent conglomerates that operate insurance companies and health care clinics."
"Prescription decisions are being made in boardrooms that focus on shareholder profits rather than in doctors' offices that prioritize patient care."
"Congressional action is warranted to restore a free market and protect consumers and small businesses."
— National Association of Attorneys General letter to congressional leadership, April 14, 2025
Section II · The Structural Constraint
The ERISA Ceiling — Why State Victories Are Partial by Design
The Employee Retirement Income Security Act of 1974 (ERISA) preempts state laws that "relate to" employee benefit plans. In practice, this means that any state insurance reform — prior authorization limits, PBM ownership bans, coverage mandates — does not apply to self-insured employer health plans. Self-insured plans cover the majority of Americans with employer-sponsored coverage, including most large employers.
What State Law CAN Reach
Fully insured plans — typically small businesses and individual market plans. State insurance mandates apply here. Meaningful protection, but limited reach.
What ERISA Shields from State Law
Self-insured employer plans — most large employers, including most Americans with job-based coverage. These plans are federally regulated. State law cannot touch them.
The Structural Implication
Every state prior authorization bill, every state PBM ownership ban, every state coverage mandate — all of them are capped by ERISA. The most ambitious state reform Tennessee could pass applies to a fraction of the people CVS covers there. CVS's lawsuit isn't just about Tennessee. It's about preserving the federal architecture that limits every state's reach.
The AGs understood this when they wrote to Congress. "Congressional action is warranted" — not because state action isn't valuable, but because ERISA means state action is constitutionally incomplete. S.3822 operates at the federal level. It does not have a ceiling.
Section III · Case Study · May 22, 2026
Tennessee — Passed, Signed, Sued Same Day
Tennessee's Freedom, Access and Integrity in Registered Pharmacy Act — the FAIR Rx Act — prohibits PBMs from owning or operating pharmacies in the state, effective January 1, 2027. It passed both chambers of Tennessee's legislature with broad bipartisan support. Republican Governor Bill Lee signed it into law on May 22, 2026. CVS filed a federal lawsuit challenging its constitutionality that same afternoon.
What It Cost to Pass
PBMs and their allies spent more than $7 million and hired more than 60 lobbyists in an attempt to kill the legislation, according to the National Community Pharmacists Association. The bill passed anyway.
CVS's Response — Filed the Same Afternoon
"We will exhaust all options we can to continue to provide pharmacy and health care services to our 1.5M+ Tennessee pharmacy patients and will be filing a lawsuit this afternoon challenging the constitutionality of this law in federal court. This unconstitutional law puts special interests and local politics ahead of patients, restricting their access to life-saving medications and undermining fair competition."
— Amy Thibault, CVS Health spokesperson, May 22, 2026
From Inside the Community — Jessica Baladad
Jessica Baladad — a breast cancer patient and advocate with 3K followers and a community of women at feelforyourlife.com — tracked the Tennessee FAIR Rx Act from within the patient advocacy community while it was still on the governor's desk, predicted the CVS lawsuit before it was filed, and documented its language publicly when it arrived. Her framing cut through what CVS's PR team spent $7M trying to prevent anyone from saying clearly: the company that claims to be protecting Tennessee patients is the only company in Tennessee that owns both a PBM and retail pharmacies. The law is targeted at them because they are the only entity doing what the law prohibits.
"CVS builds corrupt business structure. Tennessee passes FAIR Rx. CVS files a lawsuit and inverts the narrative in public statements that gaslight audiences. CVS laughs as they knit more Where's Waldo scarves for upcoming court hearings."
— Jessica Baladad, May 23, 2026
Section IV · The Precedent · 2025
Arkansas — The First State, The First Lawsuit
Arkansas passed House Bill 1150 in early 2025 — the first state law in the country to ban PBMs from owning pharmacies. CVS and Cigna filed separate lawsuits in federal court in Little Rock. A preliminary injunction has temporarily blocked enforcement while litigation proceeds.
What Arkansas Proves
Arkansas passed the law. CVS sued immediately. The law is currently paused. This is the pattern Tennessee followed. This is the pattern every state that tries will follow. The companies have the legal resources to delay state-level enforcement indefinitely while the federal version sits in committee.
Note: Arkansas AG Tim Griffin co-led the 39 AGs letter asking Congress for federal action — while simultaneously defending his own state's law in court. He is doing both because he knows why both are necessary.
Section V · The ERISA Demonstration · April 2026
Virginia — A Real Victory With a Real Ceiling
Virginia Governor Abigail Spanberger signed HB736 — limiting how often insurers can revoke prior authorizations for prescription drugs — as part of a bipartisan healthcare package that passed the Virginia General Assembly unanimously. It is a real reform. It passed without opposition. It will help patients on fully insured plans.
What Virginia's Law Does
Requires prior authorizations for prescription drugs to remain valid for at least 6 months (initial) and 12 months (renewal). Passed with zero opposition votes. Signed by a Democratic governor. Supported by the Republican AG who signed the 39 AGs federal letter.
Who It Doesn't Reach
Self-insured employer plans — which means most large employers, and the majority of Virginians with job-based coverage. ERISA exempts these plans from state insurance mandates entirely. The law that passed unanimously still cannot reach the largest share of the market.
Why Virginia Is the Clearest ERISA Demonstration
Zero opposition. Republican AG. Democratic governor. Unanimous passage. And ERISA still caps it. This is not a partisan failure or a political failure. It is a structural ceiling written into federal law in 1974 that no state legislature can legislate away. The only instrument that removes that ceiling is a federal law — which is exactly what S.3822 is.
Section VI · What the Lawsuits Prove
The Pattern — CVS's Lawsuits Are a Confession
CVS has consistently argued that state PBM ownership laws are unconstitutional. They may or may not be right in any individual case. But the pattern of the lawsuits themselves proves something CVS's PR team never intended to prove: the ownership structure matters enough to spend tens of millions of dollars defending.
| State | Law Passed | CVS Response | Status |
|---|---|---|---|
| Arkansas | HB1150 · 2025 · First state PBM ownership ban | CVS + Cigna both filed federal lawsuits | Enforcement paused — preliminary injunction |
| Tennessee | FAIR Rx Act · May 22, 2026 · Second state ban | CVS filed federal lawsuit same afternoon | Litigation active · Effective Jan 1, 2027 |
| Virginia | HB736 · April 2026 · Prior auth limits | No lawsuit — ERISA already limits reach | Effective Jan 1, 2027 · Self-insured plans exempt |
The Confession in the Pattern
CVS didn't sue Virginia. Virginia's law has an ERISA ceiling that already limits its reach — so the lawsuit isn't necessary. CVS sued Arkansas and Tennessee because those laws, if enforced, would require actual structural change to CVS's business model. The lawsuit is the tell. You don't spend $7M in lobbying and file a federal lawsuit on the same day a law is signed unless the law genuinely threatens your revenue. The states proved the argument is correct. The litigation proves why the federal version is necessary.
Section VII · The Federal Answer
The Bridge — Why This Points to S.3822
The state-level record is not an argument against the states. It is the states' own argument for why Congress must act. Thirty-nine AGs said it directly. Every CVS lawsuit says it indirectly. Every ERISA asterisk on every state bill says it structurally. The federal legislation they are all pointing toward is the same architecture your site has documented throughout the Remedy Room.
S.3822 — Break Up Big Medicine Act
Prohibits simultaneous ownership of insurers or PBMs with medical providers or pharmacies. Mandates divestiture within one year. Operates at the federal level — no ERISA ceiling. Private right of action. Treble damages. This is what the 39 AGs were asking for before Warren and Hawley introduced the bill to do it.
Read the full S.3822 analysis →S.3829 — Corporate Crimes Against Healthcare Act
Section 7 investigative authority opens the insurer's records to investigators — the evidence that the state AGs can see from the outside but cannot subpoena from within. Criminal penalties for executives. Clawback authority. The accountability mechanism S.3822's structural reform doesn't provide on its own.
Read the full S.3829 analysis →What S.3829 Gives the 39 AGs — They Don't Just Wait. They Fight.
The 39 AGs letter asks Congress for a structural prohibition. S.3829 gives them something additional: the weapons to fight alongside it. S.3829's civil enforcement authority is not limited to federal investigators — it explicitly empowers state attorneys general to bring their own actions, backed by subpoena authority that ERISA currently blocks at the state level.
What They Can Reach
Denial patterns. Reviewer credentials. Algorithmic denial systems. Overturn rate histories. All of it — inside the insurer's records — accessible via subpoena authority state insurance law currently cannot grant them.
Tim Griffin — Arkansas
Currently defending his state PBM law in federal court while asking Congress for federal action. Under S.3829 he gets a third option: bring a civil enforcement action against CVS for conduct that harmed Arkansas patients — with subpoena authority he currently doesn't have.
Jonathan Skrmetti — Tennessee
Signed the 39 AGs letter. Watched CVS sue his state the same day the governor signed FAIR Rx. Under S.3829 he becomes a participant in federal enforcement — not just a defender of state law CVS is trying to kill in court.
The letter they signed said "Congressional action is warranted." S.3829 is the congressional action that hands the authority back to them — not as state regulators ERISA can wall off, but as federal enforcement partners with the investigative tools to go inside the companies they've been fighting from the outside.
The Convergence — Every Direction Points Here
39 bipartisan AGs asked Congress for federal PBM ownership prohibition — April 2025
Arkansas passed a state ban — CVS sued, enforcement paused
Tennessee passed a state ban — CVS sued the same day it was signed
Virginia passed prior auth reform unanimously — ERISA already limits its reach
Warren + Hawley introduced S.3822 — bipartisan, federal, no ERISA ceiling — February 2026
S.3822 is still in committee. Congress has not acted on what 39 AGs asked for a year ago.
Rhode Island's Protect Mental Health Act — state-level parity enforcement — has the same ERISA ceiling. Ryan Matlock died because federal mental health parity law went unenforced. A state bill cannot fix that.
Section VIII · A Different Track · Same Ceiling
The Parity Track — Mental Health, Ryan Matlock & Rhode Island S2687
The PBM ownership fight is not the only state-level battle with an ERISA ceiling. Mental health parity enforcement runs into the same structural wall — and the human cost of that failure is documented in the Reason Room.
The Human Cost — Ryan Matlock
Ryan Matlock was 23 years old. He had survived a fentanyl overdose and checked himself into Pacifica Recovery, a residential treatment facility in Palm Desert. His insurance plan — OptumHealth Behavioral Solutions — authorized his admission. Three days later, a reviewer who never spoke with Ryan decided his authorized stay should end. His treating physician objected. His counselors objected. His mother objected. The decision stood.
Ryan called his mother from the facility. "Mom, they're going to release me soon. I'm not strong enough to do this. I need help." Three days after discharge, he died of a fentanyl overdose.
The federal Mental Health Parity and Addiction Equity Act of 2008 requires that behavioral health treatment limitations be no more restrictive than medical/surgical equivalents. California's own regulators overturn residential treatment denials 76% of the time on appeal. The law existed. The enforcement did not. Ryan Matlock did not survive the gap between the law and its enforcement.
Read Ryan Matlock's full case → The Reason RoomRhode Island's Protect Mental Health Act would require insurers to actually comply with the federal Mental Health Parity and Addiction Equity Act — collecting and evaluating data to prove their behavioral health coverage limitations don't discriminate against mental health patients compared to medical/surgical patients. It mandates "meaningful benefits" and requires insurers to document compliance or face enforcement action.
What It Would Do
Require data collection to prove parity compliance. Flag treatment limitations that produce material differences in access to behavioral health vs. medical care. Make those disparities actionable by the Insurance Commissioner. Require "core treatment" coverage for mental health in every benefit classification where medical care is covered.
The ERISA Problem
State insurance mandates don't reach self-insured employer plans. OptumHealth Behavioral Solutions — the plan that authorized and then terminated Ryan Matlock's residential treatment — operates under ERISA. A Rhode Island state parity law would not have reached the plan structure that failed him. Only federal enforcement can.
Why This Track Points to the Same Federal Gap
The Mental Health Parity and Addiction Equity Act has been federal law since 2008. Seventeen years later, California regulators still overturn 76% of residential treatment denials on appeal — which means the original denials were wrong 76% of the time. The law exists. The enforcement infrastructure does not. State parity bills like Rhode Island's S2687 are attempts to create what federal regulators have failed to build — data collection, compliance documentation, accountability mechanisms.
They face the same ERISA ceiling as every other state insurance reform. The strongest version of parity enforcement — one that could reach self-insured plans, subpoena records, and impose consequences on reviewers who systematically deny behavioral health as a business model — requires the same federal architecture as the PBM reforms. S.3829's Section 7 investigative authority is the instrument that could open an insurer's behavioral health denial patterns to investigators. Without it, the parity law is a promise that individual patients have to enforce, one appeal at a time, while their treatment window closes.
Ryan Matlock — Case IX — The Reason Room →